Cargando…
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats
The majority of patients with terminal breast cancer show signs of bone metastasis, the most common cause of pain in cancer. Clinically available drug treatment options for the relief of cancer-associated bone pain are limited due to either inadequate pain relief and/or dose-limiting side-effects. O...
Autores principales: | Shenoy, Priyank A., Kuo, Andy, Vetter, Irina, Smith, Maree T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005431/ https://www.ncbi.nlm.nih.gov/pubmed/27630567 http://dx.doi.org/10.3389/fphar.2016.00286 |
Ejemplares similares
-
Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods
por: Shenoy, Priyank, et al.
Publicado: (2017) -
The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain
por: Shenoy, Priyank A., et al.
Publicado: (2018) -
CXCR1 participates in bone cancer pain induced by Walker 256 breast
cancer cells in female rats
por: Xu, Chengfei, et al.
Publicado: (2022) -
Corydalis Saxicola Bunting Total Alkaloids Attenuate Walker 256-Induced Bone Pain and Osteoclastogenesis by Suppressing RANKL-Induced NF-κB and c-Fos/NFATc1 Pathways in Rats
por: Ju, Linjie, et al.
Publicado: (2021) -
Aprotinin and growth of Walker 256 carcinosarcoma in the rat.
por: Thomson, A. W., et al.
Publicado: (1977)